Rhumbline Advisers Taro Pharmaceutical Industries LTD Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Taro Pharmaceutical Industries LTD stock. As of the latest transaction made, Rhumbline Advisers holds 12,625 shares of TARO stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,625
Previous 9,607
31.41%
Holding current value
$0
Previous $406,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TARO
# of Institutions
19Shares Held
694KCall Options Held
0Put Options Held
0-
Krensavage Asset Management, LLC New York, NY650KShares$012.83% of portfolio
-
Analyst Ims Investment Management Services Ltd.13.6KShares$00.02% of portfolio
-
Credit Suisse Ag Zurich, V813.1KShares$00.0% of portfolio
-
Lri Investments, LLC Palm Beach Gardens, FL2KShares$00.01% of portfolio
-
Gladius Capital Management LP Chicago, IL761Shares$00.0% of portfolio
About TARO PHARMACEUTICAL INDUSTRIES LTD
- Ticker TARO
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 37,584,600
- Description
- Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...